Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Capital Expenditures (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Capital Expenditures for 6 consecutive years, with $525000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures rose 993.75% to $525000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 2349.41% increase, with the full-year FY2024 number at $490000.0, changed N/A from a year prior.
  • Capital Expenditures was $525000.0 for Q3 2025 at SANUWAVE Health, down from $1.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q2 2025 to a low of -$169000.0 in Q4 2023.
  • A 3-year average of $233600.0 and a median of $132500.0 in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: tumbled 39.07% in 2024, then soared 1159.78% in 2025.
  • SANUWAVE Health's Capital Expenditures stood at -$169000.0 in 2023, then surged by 239.64% to $236000.0 in 2024, then skyrocketed by 122.46% to $525000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Capital Expenditures are $525000.0 (Q3 2025), $1.2 million (Q2 2025), and $162000.0 (Q1 2025).